Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

Stopped Another surveillance protocol was initiated by the OFSEP (OFSEP cohort) which allows to follow all the patients, whatever their treatment.

Conditions

• Multiple Sclerosis, Relapsing-Remitting

Interventions

• DRUG: Dimethyl fumarate

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild